strengthen and diversify the public health and health care 
workforce so as to ensure the capacity of such workforce 
to effectuate advances pursuant to subsections (a) through 
(j). 
SEC. 5. INCREASING INFLUENZA VACCINE AND THERA-
PEUTICS ACCESS AND COVERAGE ACROSS 
ALL POPULATIONS. 
(a) ANNUAL REPORT ON PUBLIC COMMUNICATION 
STRATEGY.—The Director of the Centers for Disease Con-
trol and Prevention shall submit an annual report to the 
Congress on the public communication strategy of the 
Centers to increase public confidence in the safety and ef-
fectiveness of vaccines. 
(b) SENSE OF CONGRESS.—It is the sense of Con-
gress that the National Institutes of Health, the Director 
of the Centers for Disease Control and Prevention, the 
Secretary of Defense, the Secretary of Veterans Affairs, 
the Administrator of the Centers for Medicare & Medicaid 
Services, and the Commissioner of Food and Drugs should 
support research using large data sets from multiple 
sources of health data to further support and evaluate vac-
cine safety and effectiveness over multiple influenza sea-
sons. 
(c) 
ADDRESSING
MISINFORMATION
AND 
DISINFORMATION.—The Secretary of Health and Human 
VerDate Sep 11 2014 
03:54 Dec 20, 2022
Jkt 039200
PO 00000
Frm 00017
Fmt 6652
Sfmt 6201
E:\BILLS\H9476.IH
H9476
pbinns on DSKJLVW7X2PROD with $$_JOB
Services shall create partnerships to address misinforma-
tion and disinformation with respect to influenza vaccines. 
(d) COMMUNICATIONS PUBLIC-PRIVATE PARTNER-
SHIP.—The Secretary of Health and Human Services may 
provide for the establishment of a communications public- 
private partnership initiative for increasing vaccine con-
fidence that— 
(1) includes an independent, nongovernmental, 
nonprofit entity; 
(2) supports behavioral research evaluating in-
dividual behavior analysis and influence; 
(3) identifies and targets vaccine hesitant indi-
viduals; and 
(4) provides information on vaccine safety and 
effectiveness. 
(e) INCORPORATING HEALTH EQUITY INTO SEA-
SONAL AND PANDEMIC INFLUENZA PLANNING AND RE-
SPONSE.—The Director of the Centers for Disease Control 
and Prevention and the Assistant Secretary for Prepared-
ness and Response shall— 
(1) incorporate health equity into the seasonal 
and pandemic influenza planning and response pro-
grams overseen by such officials; and 
(2) in so doing— 
VerDate Sep 11 2014 
03:54 Dec 20, 2022
Jkt 039200
PO 00000
Frm 00018
Fmt 6652
Sfmt 6201
E:\BILLS\H9476.IH
H9476
pbinns on DSKJLVW7X2PROD with $$_JOB
(A) emphasize the inclusion of all popu-
lations; and 
(B) include strategies to reach commu-
nities of color, communities with lower socio-
economic status, seniors, and individuals with 
disabilities. 
(f) REPORT ON LESSONS LEARNED FROM COVID– 
19 FEDERAL RETAIL PHARMACY PROGRAM.—Not later 
than 6 months after the date of enactment of this Act, 
the Secretary of Health and Human Services shall— 
(1) submit a report to the Congress on lessons 
learned from the COVID–19 Federal Retail Phar-
macy Program; and 
(2) identify positive aspects of such Program 
that could be applied with respect to influenza. 
(g) CREATING ADMINISTRATION PATHWAYS.—The 
Secretary of Health and Human Services may award 
grants to States to create administration pathways for 
pharmacy personnel to administer influenza vaccines, in 
order to increase vaccination rates for adults and children. 
(h) STRATEGIC NATIONAL STOCKPILE.—The Sec-
retary of Health and Human Services shall incorporate 
into the Strategic National Stockpile under section 319F– 
2 of the Public Health Service Act (42 U.S.C. 247d–6b) 
VerDate Sep 11 2014 
03:54 Dec 20, 2022
Jkt 039200
PO 00000
Frm 00019
Fmt 6652
Sfmt 6201
E:\BILLS\H9476.IH
H9476
pbinns on DSKJLVW7X2PROD with $$_JOB
products needed to respond to pandemic influenza, includ-
ing through— 
(1) dynamic management of aging antivirals; 
and 
(2) diversification of stockpiled products. 
(i) MONITORING
AND DISTRIBUTING INFLUENZA 
ANTIVIRAL SUPPLIES.—The Secretary of Health and 
Human Services shall— 
(1) 
monitor 
influenza 
antiviral 
supplies 
throughout the country; and 
(2) establish a process, to be used in pandemic 
situations, to distribute products rapidly and effec-
tively to areas of urgent need in close coordination 
with manufacturers and State and local health offi-
cials. 
(j) PLAN FOR ENSURING ACCESS TO APPROPRIATE 
INFLUENZA THERAPEUTICS AND PROPHYLAXIS.— 
(1) IN GENERAL.—Not later than 1 year after 
the date of enactment of this Act, the Secretary of 
Health and Human Services shall publish a plan for 
ensuring access to appropriate influenza therapeutics 
and prophylaxis for— 
(A) high-risk patients, such as nursing 
home and pediatric patients; and 
VerDate Sep 11 2014 
03:54 Dec 20, 2022
Jkt 039200
PO 00000
Frm 00020
Fmt 6652
Sfmt 6201
E:\BILLS\H9476.IH
H9476
pbinns on DSKJLVW7X2PROD with $$_JOB
(B) high-exposure patients, such as first 
responders and health care workers. 
(2) COMMUNICATIONS EFFORTS.—The plan re-
quired by paragraph (1) shall include communica-
tions efforts to educate the public about the benefits 
of early use of influenza therapeutics and prophy-
laxis. 
SEC. 6. AUTHORIZING SUSTAINABLE FUNDING FOR THE IN-
FLUENZA ECOSYSTEM. 
(a) INFLUENZA PLANNING
AND RESPONSE PRO-
GRAM.—There 
is 
authorized 
to 
be 
appropriated 
$251,000,000 for fiscal year 2025 and each subsequent 
fiscal year for programs and activities of the Centers for 
Disease Control and Prevention relating to influenza plan-
ning and response. 
(b) STRATEGIC NATIONAL STOCKPILE.—There is au-
thorized to be appropriated $1,657,000,000 for fiscal year 
2023 and each subsequent fiscal year for the Strategic 
National Stockpile under section 319F–2 of the Public 
Health Service Act (42 U.S.C. 247d–6b). 
(c) HOSPITAL PREPAREDNESS PROGRAM.—There is 
authorized to be appropriated $474,000,000 for fiscal year 
2023 and each subsequent fiscal year for Hospital Pre-
paredness Program of the Assistant Secretary for Pre-
paredness and Response. 
VerDate Sep 11 2014 
03:54 Dec 20, 2022
Jkt 039200
PO 00000
Frm 00021
Fmt 6652
Sfmt 6201
E:\BILLS\H9476.IH
H9476
pbinns on DSKJLVW7X2PROD with $$_JOB
(d) UNIVERSAL FLU VACCINE RESEARCH.—There is 
authorized to be appropriated $260,000,000 for fiscal year 
2023 and each subsequent fiscal year for research of the 
National Institutes of Health to develop a universal flu 
vaccine. 
(e) IMMUNIZATION PROGRAM.—There is authorized 
to be appropriated $1,130,000,000 for fiscal year 2023 
and each subsequent fiscal year for the immunization pro-
gram of the Centers for Disease Control and Prevention 
under section 317 of the Public Health Service Act (42 
U.S.C. 247b). 
(f) PUBLIC HEALTH EMERGENCY PREPAREDNESS 
PROGRAM.—There is authorized to be appropriated 
$824,000,000 for fiscal year 2023 and each subsequent 
fiscal year for the Public Health Emergency Preparedness 
Program of the Centers for Disease Control and Preven-
tion. 
(g) INFECTIOUS DISEASE RAPID RESPONSE RE-
SERVE FUND.—There is authorized to be appropriated 
$35,000,000 for fiscal year 2023 and each subsequent fis-
cal year for the Infectious Disease Rapid Response Re-
serve Fund of the Centers for Disease Control and Preven-
tion. 
(h) DATA MODERNIZATION INITIATIVE.—There is 
authorized to be appropriated $250,000,000 for fiscal year 
VerDate Sep 11 2014 
03:54 Dec 20, 2022
Jkt 039200
PO 00000
Frm 00022
Fmt 6652
Sfmt 6201
E:\BILLS\H9476.IH
H9476
pbinns on DSKJLVW7X2PROD with $$_JOB
2023 and each subsequent fiscal year for the Public 
Health Data Modernization Initiative of the Centers for 
Disease Control and Prevention. 
(i) HEALTH DEFENSE OPERATIONS BUDGET MAT-
TERS.— 
(1) DESIGNATION.—Section 251(b)(2) of the 
Balanced Budget and Emergency Deficit Control 
Act of 1985 (2 U.S.C. 901(b)(2)) is amended by 
adding at the end the following: 
‘‘(F) HEALTH DEFENSE OPERATIONS.—(i) 
If, for any fiscal year, appropriations for discre-
tionary accounts are enacted that the Congress 
designates in statute on an account by account 
basis as being for health defense operations, 
then the adjustment for that fiscal year shall be 
the total of such appropriations for that fiscal 
year. 
‘‘(ii) Any report or explanatory statement 
accompanying an appropriations Act that con-
tains an account with amounts that are des-
ignated as being for health defense operations 
pursuant to clause (i) shall specify each pro-
gram, project, or activity that will be funded by 
such amounts, and a specific dollar amount pro-
VerDate Sep 11 2014 
03:54 Dec 20, 2022
Jkt 039200
PO 00000
Frm 00023
Fmt 6652
Sfmt 6201
E:\BILLS\H9476.IH
H9476
pbinns on DSKJLVW7X2PROD with $$_JOB
vided for each such program, project, or activ-
ity.’’. 
(2) PROFESSIONAL BYPASS BUDGET.—Title IV 
of the Public Health Service Act (42 U.S.C. 281 et 
seq.) is amended by inserting after section 402B the 
following: 
‘‘SEC. 
402C. 
HEALTH 
DEFENSE 
OPERATIONS 
PROFES-
SIONAL BYPASS BUDGET. 
‘‘(a) IN GENERAL.—For fiscal year 2024 and each 
fiscal year thereafter, the Director of the Centers for Dis-
ease Control and Prevention, the Director of the National 
Institutes of Health, and the Assistant Secretary for Pre-
paredness and Response shall prepare and submit directly 
to the President for review and transmittal to Congress, 
after reasonable opportunity for comment, but without 
change, by the Secretary of Health and Human Services, 
an annual budget estimate (including an estimate of the 
number and type of personnel needs for the Institutes) 
for amounts to be designated as being for health defense 
operations pursuant to subparagraph (F) of section 
251(b)(2) of the Balanced Budget and Emergency Deficit 
Control Act of 1985. 
‘‘(b) PROGRAMS, PROJECTS, AND ACTIVITIES.—Any 
budget estimate submitted pursuant to subsection (a) by 
the Director shall include any program, project, or activity 
VerDate Sep 11 2014 
03:54 Dec 20, 2022
Jkt 039200
PO 00000
Frm 00024
Fmt 6652
Sfmt 6201
E:\BILLS\H9476.IH
H9476
pbinns on DSKJLVW7X2PROD with $$_JOB
that received funds designated under such subparagraph 
(F) for the fiscal year during which such budget is sub-
mitted, except that the Director may modify the programs, 
projects, or activities contained in such budget estimate 
as circumstances warrant.’’. 
Æ 
VerDate Sep 11 2014 
03:54 Dec 20, 2022
Jkt 039200
PO 00000
Frm 00025
Fmt 6652
Sfmt 6301
E:\BILLS\H9476.IH
H9476
pbinns on DSKJLVW7X2PROD with $$_JOB